Agilent Technologies, Inc. - Diagnostics and Genomics ClearSeq Comprehensive Cancer,96, XT
The Agilent ClearSeq Comprehensive Cancer, 96 reactions, XT (part number 5190-8012) is a targeted next-generation sequencing (NGS) panel designed for comprehensive cancer research. This panel enables the detection of genetic variants across a broad range of cancer-related genes, supporting the identification of somatic mutations relevant to oncology studies. The kit is optimized for high-throughput workflows and is compatible with Agilent's SureSelect XT library preparation system, providing reliable performance and streamlined sample processing for up to 96 reactions. It is intended for research use only and not for diagnostic procedures.